
To help keep our community authentic, we're showing information about accounts on Linktree.
Practical Dermatology has been a member of Linktree for 3 years and joined in September 2022. The social media accounts linked to from Practical Dermatology are: • Facebook • Instagram • LinkedIn • X Besides social media accounts, practicaldermatology has populated their site with: • July 2026 - PracticalDermatology • Picankibart Shows Skin Clearance in Plaque Psoriasis: Analysis - PracticalDermatology • Study: Dupilumab Shows Long-Term Disease Control in Pediatric Atopic Dermatitis - PracticalDermatology • Meta-analysis: Topical Ivermectin, Encapsulated BPO Show Strongest Efficacy in Rosacea - PracticalDermatology • FDA Grants SKYRIZI Approval to Children With Plaque Psoriasis and PsA - - PracticalDermatology • Letter Questions Strength of Evidence Linking Hair Relaxers to Uterine Cancer - - PracticalDermatology • Optometry's Meeting registration • Advances in Ocular Drug Delivery - • DermWireTV: Dermatologists React to the Valisure Report; FDA Approves New Treatment for Frown Lines • ESCD 2026: New Data Show Ongoing Burden of Chronic Hand Eczema - - PracticalDermatology • DermWire TV: Maui Derm Highlights, Plus New and Emerging Treatments for HS and Acne • FDA Expands Dupixent CSU Indication to Children as Young as 2 Years - - PracticalDermatology • DermWireTV: Atopic Dermatitis Guidelines, Derm Devices, and New Research - Practical Dermatology • Comparative Study Finds No Significant Melanoma Mortality Reduction From German Screening Initiative - - PracticalDermatology • FDA Approves Roflumilast for Seborrheic Dermatitis in Young Patients - Practical Dermatology • The Future of Treatment and Research for Giant Congenital Melanocytic Nevi - PracticalDermatology • New In My Practice: Cosmeceutical • BE BOLD at 16 Weeks: Bimekizumab Outperforms Risankizumab for PsA - - PracticalDermatology • |NEW EPISODE| DermwireTV: Birch Triterpenes Gel Gets FDA Approval for EB • May/June 2026 - PracticalDermatology • Bipolar Radiofrequency Microneedling for the Treatment of Facial Lipoma: A Case Study • Analysis: Capecitabine Shows Clinical Activity in Advanced Head and Neck Cutaneous SCC - - PracticalDermatology • From Clinician to Investigator: Staying Ethical in Industry-Sponsored Trials • Best Practices for Fitting Scleral Lenses - • Is Lower Extremity Lymphedema a Risk for Skin Cancer? • YoungMD Connect + Almirall Virtual Session: Optimizing Acne Therapy • Important FDA Approvals in 2023 Lead to New, Exciting Treatments in 2024 - Practical Dermatology • Ultrasound Detects Subclinical Joint and Nail Changes in Pediatric Psoriasis - - PracticalDermatology • Review: Botulinum Toxin Shows Potential in Acne Treatment - - PracticalDermatology • FDA Approves OTC Switch for Galderma’s Differin Epiduo Acne Gel - - PracticalDermatology • Ixekizumab Plus Tirzepatide Improves PASI and Weight Loss in Psoriasis Study - - PracticalDermatology • Isotretinoin Use in Adolescence Not Linked to Reduced Adult Height: Analysis - - PracticalDermatology • BE BOLD: Bimekizumab Tops Risankizumab for ACR50 Outcomes - - PracticalDermatology • From SCALE 2026: Practical Strategies for Treating GLP-1–Related Aesthetic Changes - - PracticalDermatology • From SCALE 2026: Dermatologists Navigate the Expanding Role of GLP-1s in Skin Health and Aesthetic Care - - PracticalDermatology • Text-Messaging Program Improves Cardiovascular Risk Behaviors in Psoriasis - - PracticalDermatology • Meta-Analysis: HS Linked with Elevated Cardiovascular Risk - - PracticalDermatology • Iron Oxides in Tinted Sunscreens May Improve Hyperpigmentation Protection: Study - - PracticalDermatology • Long-Term Dupilumab Use Linked to Delayed Relapse in AD: Study - - PracticalDermatology • Report: One-Third of Patients With Vitiligo Receive No Follow-Up Treatment - - PracticalDermatology • Analysis: Black Children Show Lower Dermatology Specialty Care Use Despite Higher Disease Frequency - - PracticalDermatology • The Science of Skin: Hidradenitis Suppurativa - • Topical NAC Plus Doxycycline Shows Benefit in Moderate Acne - - PracticalDermatology • REGISTER TODAY! Genesis | Tell-All Tribune • Analysis: PRS Improves Melanoma Risk Prediction - - PracticalDermatology • Dr. Lisa Swanson Presents on Communication, Therapeutics, and Confidence in Treating Children at Noah - - PracticalDermatology • Incyte Reports Positive Vitiligo Phase 3 Data Supporting JAK Pipeline - - PracticalDermatology • BPO Not Linked with Higher Malignancy Risk: Meta-analysis - - PracticalDermatology • AI Dermatology Tools Improve Patient Diagnostic Accuracy in Survey Study - - PracticalDermatology • IEC Establishes Global Definitions for AD Disease Control and Remission - - PracticalDermatology • FDA Flags Six Additional Gel Nail Removers for Banned Chemical - - PracticalDermatology • Imaging Bests Exam in Detecting Nodal Metastases in High-Risk cSCC - - PracticalDermatology • April 2026 - PracticalDermatology • AAD Pediatric Guidelines Give Strong Backing to Roflumilast Cream - - PracticalDermatology • CKD Linked to Higher Complication Risk After Mohs Surgery - - PracticalDermatology • Meta-Analysis: Similar AK Clearance With PDT and Cryotherapy - - PracticalDermatology • Analysis: No Lymphoma Signal With Topical Calcineurin Inhibitors - - PracticalDermatology • Pushing the Envelope in PN Research - PracticalDermatology • Paper: AI Gains Ground in Cosmetic Dermatology Workflows - - PracticalDermatology • CLL Linked to Higher Skin Cancer Risk and Worse Outcomes in Nationwide Study - - PracticalDermatology • Phase 3 Data Highlight Early and Broad Response With Deuruxolitinib - - PracticalDermatology • Early Inflammatory Signals May Precede Alopecia Areata Diagnosis - - PracticalDermatology • Lebrikizumab Shows Durable Efficacy Through 4 Years in Atopic Dermatitis - - PracticalDermatology • From Diagnosis to Prognosis: Using MyPath® Melanoma and DecisionDx®-Melanoma to Help Guide Patient Management Decisions - PracticalDermatology • IMMpactful: Risankizumab Outperforms Deucravacitinib in Moderate Psoriasis at 16 Weeks - - PracticalDermatology • TRuE-AD4: Ruxolitinib Cream Improves QoL and Sleep in Moderate AD - - PracticalDermatology • AD-VISE: Better Patient Outcomes Tied to Achieving MDA at 6 Months - - PracticalDermatology • Long-term Upadacitinib Data Show Low Rates of MACE, Malignancy - - PracticalDermatology • ICONIC-LEAD: Durable Psoriasis Clearance Through 52 Weeks with Icotrokinra - - PracticalDermatology • What New Secukinumab Data Mean for HS Patients: A Q&A with Dr. April Armstrong - - PracticalDermatology • Bimekizumab Shows Durable Psoriasis Clearance and 3-Year HS Control - - PracticalDermatology • Cannabis Use Linked to Lower BCC Risk, No Change in Melanoma or cSCC: Study - - PracticalDermatology • Topical Treatments for HS - March 2026 Issue • Prospective Data Show Comparable Performance Between AI and Dermatologists - - PracticalDermatology • The Hidradenitis Suppurativa Therapeutic Pipeline - March 2026 Issue • New Grants Expand Teledermatology Access in the Bronx and Los Angeles - - PracticalDermatology • March 2026 - PracticalDermatology • Study: Potential Link Between Lesional IgG Autoantibodies and HS Disease Severity - - PracticalDermatology • Lutikizumab Improves Clinical Response Rates in Moderate to Severe HS: Analysis - - PracticalDermatology • Analysis: Long Waits for Pediatric Dermatology Appointments Across US - - PracticalDermatology • FDA Approves Icotrokinra for Moderate-to-Severe Plaque Psoriasis - - PracticalDermatology • Dermatology Residents Show Gains After Targeted Topical Formulation Education - - PracticalDermatology • ADorable-1 Trial Meets Endpoints for EBGLYSS in Children With Atopic Dermatitis - - PracticalDermatology • FDA Expands Secukinumab to Adolescents With Moderate to Severe HS - - PracticalDermatology • Register here for Music City Scale! • BE BOLD: Bimekizumab Shows Superiority Over IL-23 Inhibitor in Psoriatic Arthritis - - PracticalDermatology • Review: Gut Microbiota Dysbiosis Linked With AD, Psoriasis, and HS - - PracticalDermatology • Baricitinib, Ritlecitinib, and Deuruxolitinib Demonstrate Efficacy in Severe AA - - PracticalDermatology • Diclofenac, Silymarin Show Promise for Preventing Chemotherapy-Induced Hand-Foot Syndrome: Meta-analysis - - PracticalDermatology • Practical Dermatology Roundtable: The Role of Adjuvant Skin Cleansing and Moisturizing in Treating Psoriasis and Other Inflammatory Diseases - ReachMD • |NEW ISSUE| March 2024 "Facial Pigmentary Disorders: A Review of Current Treatments" • Not All PDE4 Inhibitors Are the Same • Rosacea and Beyond: PDT Patient Success Stories • Noah Worcester 2024: Dr. Bar on Surgical Procedures • Noah Worcester 2024: Dr. Bridges on Practice Management • Dapsone Gel Shows Promise for Treating Acne in Skin of Color • Journal Club: Oral JAK Inhibitors in Moderate-to-Severe AD • DermwireTV: FDA Approves Humira Biosimilar; Study Examines Trifarotene for Acne Lesions • Study Shows Pediatric Skin Diseases Have Hidden Impact on Mental Health • DermWire TV: Factors Affecting Long-term Antibiotic Prescriptions for Acne • The Little Ones: Perspectives on Pediatric Psoriasis and AD • Benzoyl Peroxide (BPO) Interviews • Atopic Dermatitis and Psoriasis: Treatments, Considerations, and What’s Coming • New Analysis Provides Evidence-based Recommendations for Vitiligo in Pediatric Patients • DermWireTV: New Data Presented for Atopic Dermatitis and Prurigo Nodularis Candidates at AAD • How Air Pollution Affects the Skin • Is this the Golden Age of Hair Loss Treatment? • Report: Unacceptably High Benzene Levels Detected in Numerous Acne Products Containing BPO • How Ichthyosis Can Affect Mental Health—And How We Can Address It • Six Dermatology Biotechs Combine to Form Alys Pharmaceuticals • Social Media as a Force for Good: How to Think Like a B Corp - Practical Dermatology • Across the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare • Cutaneous Signet Ring Squamous Cell Carcinoma: Case Presentation and Brief Literature Review • The Importance of Keeping Up with New Developments • Achieve Skin Tightening in 1-2-3 - Practical Dermatology • Why Assessing Vitiligo Activity is Critical for Limiting Spread - Practical Dermatology • How Combination Treatments Can Address Unmet Needs • How Dermatological Practices Can Integrate Clinical Research - Practical Dermatology • Study: Transgender Individuals Experience Stigma, Treatment Barriers - Practical Dermatology • What’s Great About Your Practice? And Why Does That Really Matter? - Practical Dermatology • Angioleiomyoma in a Rare Location - Practical Dermatology • Treatment of Psychodermatological Conditions Using N-acetylcysteine • Vitiligo: An Update on Treatment Options • DermWireTV • Physician Spotlight: Sue Ellen Cox, MD • Regenerative Medicine in Action: Reprogramming Tissue Mechanically to Heal Wounds, Rejuvenate Skin • Dealing With Unhappy Cosmetic Patients • Demystifying Itch: Does S. aureus Kickstart a Molecular Chain Reaction That Culminates in the Urge to Scratch? • More Photos of Patients with Psoriasis Needed in Studies • How Early Experience With PDT Can Provide Career Pathways • YoungMD Connect | Dermatology & Aesthetics • Subscribe to Practical Dermatology today!